secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0001193125-26-197192
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed Q3 revenue $1.43B (+11%); GAAP EPS $2.74, dividend $0.60
---------------------------------------------------------------

- Revenue $1,431.4M (+11% reported, +8% constant currency).
- GAAP diluted EPS $2.74 (+10% YoY); non-GAAP diluted EPS $2.86 (+21% YoY).
- GAAP gross margin 62.2% (+290 bps); non-GAAP gross margin 62.8% (+290 bps).
- Quarterly dividend $0.60/share declared; record 5/14/2026, payable 6/18/2026.
- Operating cash flow $554M; $262M returned via buybacks and dividends in Q3.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312526197192/0001193125-26-197192-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312526197192/d146862d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-197192

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer